Latest Insider Transactions at Cumberland Pharmaceuticals Inc (CPIX)
This section provides a real-time view of insider transactions for Cumberland Pharmaceuticals Inc (CPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CUMBERLAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CUMBERLAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,105
+1.59%
|
$10,210
$2.79 P/Share
|
|
May 13
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.88 P/Share
|
|
May 13
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.88 P/Share
|
|
May 13
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.88 P/Share
|
|
May 13
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.88 P/Share
|
|
May 12
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.86 P/Share
|
|
May 12
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.86 P/Share
|
|
May 12
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.86 P/Share
|
|
May 12
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.86 P/Share
|
|
May 11
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.68 P/Share
|
|
May 11
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.68 P/Share
|
|
May 11
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.68 P/Share
|
|
May 11
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.68 P/Share
|
|
May 10
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.71 P/Share
|
|
May 10
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.71 P/Share
|
|
May 10
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.71 P/Share
|
|
May 10
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.71 P/Share
|
|
May 07
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.73 P/Share
|
|
May 07
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.73 P/Share
|
|
May 07
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.73 P/Share
|
|
May 07
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.73 P/Share
|
|
May 06
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.74 P/Share
|
|
May 06
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.74 P/Share
|
|
May 06
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.74 P/Share
|
|
May 06
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.74 P/Share
|
|
May 05
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.73 P/Share
|
|
May 05
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.73 P/Share
|
|
May 05
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.73 P/Share
|
|
May 05
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.73 P/Share
|
|
May 04
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.66 P/Share
|
|
May 04
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.66 P/Share
|
|
May 04
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.66 P/Share
|
|
May 04
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.66 P/Share
|
|
May 03
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.66 P/Share
|
|
May 03
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.66 P/Share
|
|
May 03
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.66 P/Share
|
|
May 03
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.66 P/Share
|
|
Apr 30
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.78 P/Share
|
|
Apr 30
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.78 P/Share
|
|
Apr 30
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.78 P/Share
|
|
Apr 30
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.78 P/Share
|
|
Apr 29
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.89 P/Share
|
|
Apr 29
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.89 P/Share
|
|
Apr 29
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.89 P/Share
|
|
Apr 29
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.89 P/Share
|
|
Apr 28
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.94 P/Share
|
|
Apr 28
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.94 P/Share
|
|
Apr 28
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.94 P/Share
|
|
Apr 28
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
80
+0.05%
|
$160
$2.94 P/Share
|
|
Apr 27
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.94 P/Share
|